市場調査レポート
商品コード
1451229
睡眠時無呼吸用デバイス市場レポート:製品タイプ、エンドユーザー、地域別、2024-2032Sleep Apnea Devices Market Report by Product Type (Therapeutic Devices, Diagnostic Devices), End-User (Hospitals and Clinics, Sleep Laboratories, Homecare Settings, and Others), and Region 2024-2032 |
|||||||
カスタマイズ可能
|
睡眠時無呼吸用デバイス市場レポート:製品タイプ、エンドユーザー、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 139 Pages
納期: 2~3営業日
|
世界の睡眠時無呼吸用デバイスの市場規模は2023年に80億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率(CAGR)は6%を示し、2032年には138億米ドルに達すると予測しています。
睡眠時無呼吸症候群、または睡眠呼吸障害(SDB)は、睡眠中に脳への酸素供給が阻害される急性の病状です。気道の閉塞により、不規則な呼吸パターンと大きないびきを引き起こし、患者はしばしば息を切らします。睡眠時無呼吸症候群の診断および治療には、CPAP(Continuous Positive Airway Pressure)、BiPAP(Bilevel Positive Airway Pressure)、VPAP(Variable Positive Airway Pressure)などの装置が用いられ、睡眠中の患者の呼吸機能やその他の身体機能を評価します。これとは別に、下顎前方移動装置(MAD)や舌保持装置を含む数多くの口腔装置も、軽度から中等度の睡眠時無呼吸症候群の治療に利用されています。
閉塞性睡眠時無呼吸症候群(OSA)、中枢性睡眠時無呼吸症候群、複合型睡眠時無呼吸症候群の有病率の増加は、市場の成長を促進する主な要因の一つです。このような疾患は、老年人口や糖尿病、高血圧、心血管疾患(CVDs)などの他の疾患を患っている人々の間で非常に普及しており、先進国と新興国の両方で製品の採用を促進しています。さらに、OSAの診断のために睡眠パターン、心血管、オキシメトリー、呼吸パラメーターを検査するOOC(Out-of-Center)検査装置などの製品革新も、もう一つの主要な成長促進要因として作用しています。ヘルスケアインフラの改善や、睡眠時無呼吸症候群の長期化に関する意識の高まりなどのその他の要因に加え、様々なブランドによる小型化と手頃な価格の機器の発売が、市場をさらに牽引すると予測されます。
閉塞性睡眠時無呼吸症候群(OSA)、中枢性睡眠時無呼吸症候群、複合型睡眠時無呼吸症候群の有病率の増加は、市場の成長を促進する主な要因の一つです。このような疾患は、老年人口や糖尿病、高血圧、心血管疾患(CVDs)などの他の疾患を患っている人々の間で非常に普及しており、先進国と新興国の両方で製品の採用を促進しています。さらに、OSAの診断のために睡眠パターン、心血管、オキシメトリー、呼吸パラメーターを検査するOOC(Out-of-Center)検査装置などの製品革新も、もう一つの主要な成長促進要因として作用しています。ヘルスケアインフラの改善や、睡眠時無呼吸症候群の長期化に関する意識の高まりなどのその他の要因に加え、様々なブランドによる小型化と手頃な価格の機器の発売が、市場をさらに牽引すると予測されます。
The global sleep apnea devices market size reached US$ 8.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 13.8 Billion by 2032, exhibiting a growth rate (CAGR) of 6% during 2024-2032.
Sleep apnea, or sleep-disordered breathing (SDB), is an acute medical condition in which oxygen supply to the brain is obstructed during sleep. It is caused by blockages in the airway resulting in irregular breathing patterns and loud snoring, with the individual often gasping for breath. Sleep apnea diagnostic and therapeutic devices, such as Continuous Positive Airway Pressure (CPAP), Bilevel Positive Airway Pressure (BiPAP) and Variable Positive Airway Pressure (VPAP) machines, are used to evaluate the patient's respiratory and other bodily functions during sleep. Apart from this, numerous oral devices, including the Mandibular Advancement Device (MAD) and tongue retaining device, are also utilized to treat mild to moderate cases of sleep apnea.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
The increasing prevalence of obstructive sleep apnea disorder (OSA), central sleep apnea and complex sleep apnea syndrome, are among the key factors driving the growth of the market. Such disorders are highly prevalent among the geriatric population and individuals suffering from other ailments, such as diabetes, hypertension and cardiovascular diseases (CVDs), which is facilitating product adoption across both the developed and emerging nations. Furthermore, product innovations, including Out-of-Center (OOC) testing devices that examine sleep patterns, cardiovascular, oximetry and respiratory parameters for the diagnosis of OSA is also acting as another major growth-inducing factor. Other factors, including improving healthcare infrastructure and growing awareness regarding the prolonged effects of sleep apnea, along with the miniaturization and launch of affordable devices by various brands, are projected to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global sleep apnea devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type and end-user.
Therapeutic Devices
Positive Airway Pressure (PAP) Devices
Oral Devices
Nasal Devices
Chin Straps
Others
Diagnostic Devices
Actigraphs
Polysomnography Devices
Sleep Screening Devices
Others
Hospitals and Clinics
Sleep Laboratories
Homecare Settings
Others
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
The competitive landscape of the industry has also been examined with some of the key players being BMC Medical Co., Braebon Medical Corporation, Cadwell Laboratories, CareFusion Corp., Curative Medical, Devilbiss Healthcare, Fisher & Paykel Healthcare, GE Healthcare, Invacare, Oventus Medical, Panthera Dental, ResMed, Somnomed Ltd., Vyaire Medical Inc., Whole You Inc., etc.